Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications von Kortekaas Krohn, I., Shikhagaie, M. M., Golebski, K., Bernink, J. H., Breynaert, C., Creyns, B., Diamant, Z., Fokkens, W. J., Gevaert, P., Hellings, P., Hendriks, R. W., Klimek, L., Mjösberg, J., Morita, H., Ogg, G. S., O'Mahony, L., Schwarze, J., Seys, S. F., Shamji, M. H., Bal, S. M.

Volltext

OP37 Fibrogenesis in chronic DSS colitis is driven by an innate lymphoid cell-independent innate immune response von Creyns, B, Cremer, J, De Hertogh, G, Boon, L, Ferrante, M, Vermeire, S, Van Assche, G, Ceuppens, J, Breynaert, C

Volltext

P063 The immunological landscape of intestinal fibrosis in Crohn’s Disease von Jacobs, I, Creyns, B, Dragoni, G, Cremer, J, Bislenghi, G, D’Hoore, A, Ke, B J, Matteoli, G, De Hertogh, G, Ferrante, M, Joao, G S, Breynaert, C, Vermeire, S, Verstockt, B, Vanuytsel, T

Volltext

P001 Multi-omic data integration assisted identification of molecular features contributing to disease heterogeneity in Crohn's disease von Sudhakar, P, Verstockt, B, Creyns, B, Cremer, J, van Assche, G, Korcsmaros, T, Ferrante, M, Vermeire, S

Volltext

DOP26 Biological therapy increases NCR+ ILC3 levels in IBD patients von Creyns, B, Verstockt, B, Cremer, J, Ballet, V, Ferrante, M, Vermeire, S, Ceuppens, J, Van Assche, G, Breynaert, C

Volltext

P067 Proteins citrullination and Crohn’s disease: PAD4 but not PAD2 is a strong marker of ileal inflammation von Dragoni, G, Creyns, B, De Hertogh, G, Verstockt, B, Wollants, W J, Ke, B J, Marcellis, L, Matteoli, G, D’Hoore, A, Galli, A, Ferrante, M, Vermeire, S

Volltext

DOP83 Intestinal fibrosis in Crohn’s disease patients is marked by up-regulation of innate immune cells and mucosal B cells von Creyns, B, Gabriele, D, Jonathan, C, Verstockt, B, Bislenghi, G, Marc, F, Vermeire, S, Van Assche, G, Ceuppens, J, D’Hoore, A, De Hertogh, G, Breynaert, C

Volltext

DOP018 Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn’s disease von Creyns, B, Verstockt, B, Cremer, J, Ferrante, M, Vermeire, S, Jan, C, Van Assche, G, Breynaert, C

Volltext

P035 Serum markers predict outcome to ustekinumab in patients with refractory Crohn’s disease and provide insides in the mechanism of action von Verstockt, B, Vermeire, S, Verstockt, S, Creyns, B, Ardeshir Davani, N, Breynaert, C, Van Assche, G, Ferrante, M

Volltext

DOP70 An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's disease von Verstockt, B, Sudahakar, P, Creyns, B, Verstockt, S, Cremer, J, Wollants, W-J, Organe, S, Korcsmaros, T, Madgwick, M, Van Assche, G, Breynaert, C, Vermeire, S, Ferrante, M

Volltext